Notice of Closed Meeting, 5438-5439 [2020-01623]
Download as PDF
khammond on DSKJM1Z7X2PROD with NOTICES
5438
Federal Register / Vol. 85, No. 20 / Thursday, January 30, 2020 / Notices
Parties: CMA CGM S.A. and COSCO
Shipping Lines Co., Ltd.
Filing Party: Draughn Arbona, CMA
CGM (America) LLC.
Synopsis: The Agreement authorizes
CMA CGM and COSCO to jointly
operate a liner service in the trade
between the U.S. Gulf Coast, Brazil,
Panama, Jamaica, and Mexico.
Proposed Effective Date: 1/21/2020.
Location: https://www2.fmc.gov/
FMC.Agreements.Web/Public/
AgreementHistory/26455.
Agreement No.: 012146–003.
Agreement Name: HLAG/Maersk
USWC-Mediterranean Vessel Sharing
Agreement.
Parties: Hapag Lloyd AG and Maersk
A/S.
Filing Party: Wayne Rohde; Cozen
O’Connor.
Synopsis: The amendment changes
the name of Maersk Line A/S to Maersk
A/S.
Proposed Effective Date: 1/22/2020.
Location: https://www2.fmc.gov/
FMC.Agreements.Web/Public/
AgreementHistory/308.
Agreement No.: 012307–004.
Agreement Name: Maersk/APL Slot
Exchange Agreement.
Parties: Maersk A/S; APL Co. Pte.
Ltd.; and American President Lines,
LLC.
Filing Party: Wayne Rohde; Cozen
O’Connor.
Synopsis: The amendment changes
the name of Maersk Line A/S to Maersk
A/S, updates the name of the Agreement
accordingly, and makes changes to the
space charter volumes under the
Agreement.
Proposed Effective Date: 1/23/2020.
Location: https://www2.fmc.gov/
FMC.Agreements.Web/Public/
AgreementHistory/176.
Agreement No.: 201322–001.
Agreement Name: Maersk/Matson
Space Charter Agreement.
Parties: Maersk A/S and Matson
Navigation Company, Inc.
Filing Party: Wayne Rohde; Cozen
O’Connor.
Synopsis: The amendment changes
the name of Maersk Line A/S to Maersk
A/S.
Proposed Effective Date: 1/23/2020.
Location: https://www2.fmc.gov/
FMC.Agreements.Web/Public/
AgreementHistory/24440.
Dated: January 24, 2020.
Rachel Dickon,
Secretary.
BILLING CODE 6731–AA–P
16:56 Jan 29, 2020
Change in Bank Control Notices;
Acquisitions of Shares of a Bank or
Bank Holding Company
The notificants listed below have
applied under the Change in Bank
Control Act (Act) (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire shares of a bank
or bank holding company. The factors
that are considered in acting on the
notices are set forth in paragraph 7 of
the Act (12 U.S.C. 1817(j)(7)).
The applications listed below, as well
as other related filings required by the
Board, if any, are available for
immediate inspection at the Federal
Reserve Bank indicated. The
applications will also be available for
inspection at the offices of the Board of
Governors. Interested persons may
express their views in writing on the
standards enumerated in paragraph 7 of
the Act.
Comments regarding each of these
applications must be received at the
Reserve Bank indicated or the offices of
the Board of Governors, Ann E.
Misback, Secretary of the Board, 20th
and Constitution Avenue NW,
Washington, DC 20551–0001, not later
than February 17, 2020.
A. Federal Reserve Bank of Atlanta
(Kathryn Haney, Assistant Vice
President) 1000 Peachtree Street NE,
Atlanta, Georgia 30309. Comments can
also be sent electronically to
Applications.Comments@atl.frb.org:
1. William T. Taylor, Merritt Island,
Florida; to retain voting shares of CBOS
Bankshares, Inc., and thereby indirectly
retain voting shares of Community Bank
of the South, both of Merritt Island,
Florida.
Board of Governors of the Federal Reserve
System, January 27, 2020.
Ann Misback,
Secretary of the Board.
[FR Doc. 2020–01666 Filed 1–29–20; 8:45 am]
BILLING CODE P
GOVERNMENT ACCOUNTABILITY
OFFICE
Request for Nominations for the
Physician-Focused Payment Model
Technical Advisory Committee (PTAC)
U.S. Government
Accountability Office (GAO).
ACTION: Request for letters of
nomination and resumes.
AGENCY:
The Medicare Access and
CHIP Reauthorization Act of 2015
established the Physician-Focused
SUMMARY:
[FR Doc. 2020–01665 Filed 1–29–20; 8:45 am]
VerDate Sep<11>2014
FEDERAL RESERVE SYSTEM
Jkt 250001
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
Payment Model Technical Advisory
Committee to provide comments and
recommendations to the Secretary of
Health and Human Services on
physician payment models and gave the
Comptroller General responsibility for
appointing its members. GAO is now
accepting nominations of individuals
for this committee.
DATES: Letters of nomination and
resumes should be submitted no later
than February 28, 2020, to ensure
adequate opportunity for review and
consideration of nominees prior to
appointment. Appointments to fill open
spots on PTAC are expected to be made
in June 2020. Other appointments will
be made in October 2020.
ADDRESSES: Submit letters of
nomination and resumes by either of the
following methods: Email:
PTACcommittee@gao.gov or Mail: U.S.
GAO, Attn: PTAC Nominations, 441 G
Street NW, Washington, DC 20548.
FOR FURTHER INFORMATION CONTACT: Greg
Giusto at (202) 512–8268 or giustog@
gao.gov if you do not receive an
acknowledgement within a week of
submission or if you need additional
information. For general information,
contact GAO’s Office of Public Affairs,
(202) 512–4800.
Authority: Pub. L. 114–10, Sec. 101(e), 129
Stat. 87, 115 (2015).
Gene L. Dodaro,
Comptroller General of the United States.
[FR Doc. 2020–01699 Filed 1–29–20; 8:45 am]
BILLING CODE 1610–02–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
E:\FR\FM\30JAN1.SGM
30JAN1
Federal Register / Vol. 85, No. 20 / Thursday, January 30, 2020 / Notices
unwarranted invasion of personal
privacy.
Name of Committee: Disease, Disability,
and Injury Prevention and Control Special
Emphasis Panel (SEP)- SIP20–009, StateBased Health, Budget Impact and CostEffectiveness of Improved Coverage and
Uptake of Smoking Cessation.
Date: April 28, 2020.
Time: 11:00 a.m.—6:00 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact: Jaya
Raman Ph.D., Scientific Review Officer, CDC,
4770 Buford Highway, Mailstop F80, Atlanta,
Georgia 30341; Telephone: (770) 488–6511;
kva5@cdc.gov.
The Director, Strategic Business Initiatives
Unit, Office of the Chief Operating Officer,
Centers for Disease Control and Prevention,
has been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–01623 Filed 1–29–20; 8:45 am]
in Puerto Rico; RFA–CK–20–002,
Detection and Characterization of
Emerging Vector-Borne Zoonotic
Pathogens in Indonesia; and RFA–CK–
20–003, Modeling Infectious Diseases in
Healthcare Research Projects to Improve
Prevention Research and Healthcare
Delivery (MInD Healthcare).
Date: March 31, 2020–April 1, 2020
Time: 10:00 a.m.–5:00 p.m., EDT
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road, NE, Mailstop US8–1,
Atlanta, Georgia 30329–4027;
Telephone: (404) 718–8833; gca5@
cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2020–01619 Filed 1–29–20; 8:45 am]
BILLING CODE 4163–18–P
Centers for Disease Control and
Prevention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
khammond on DSKJM1Z7X2PROD with NOTICES
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)RFA–CK–20–001, Enhanced
Surveillance and Control of Arboviruses
VerDate Sep<11>2014
16:56 Jan 29, 2020
Jkt 250001
Centers for Disease Control and
Prevention
Meeting of the Community Preventive
Services Task Force (CPSTF)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
The CDC within the HHS
announces the next meeting of the
CPSTF on February 12, 2020.
DATES: The meeting will be held on
Wednesday, February 12, 2020, from
8:30 a.m. to 5:00 p.m. EST.
ADDRESSES: The CPSTF meeting will be
held via web conference. Information
regarding meeting logistics will be
available on the Community Guide
website (www.thecommunityguide.org)
closer to the date of the meeting.
FOR FURTHER INFORMATION CONTACT:
Onslow Smith, Community Guide
Office, Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
SUMMARY:
PO 00000
Frm 00073
Fmt 4703
Sfmt 4703
5439
E–69, Atlanta, GA 30329, phone: (404)
498–6778, email: CPSTF@cdc.gov.
SUPPLEMENTARY INFORMATION:
Meeting Accessibility: This CPSTF
meeting will be a one-day session held
virtually. The morning session will
consist of internal CPSTF business
related to its 2020 process for
establishing its priority topics for 2021–
2025. The afternoon session will consist
of deliberation on systematic reviews of
literature. The afternoon session is open
to the public from 1:00 to 5:00 p.m. EST.
All participants who would like to
attend the afternoon session must
register by 5:00 p.m. EST on Friday,
February 7, 2020. Participants will
receive registration confirmation with
web conference meeting instructions
within two business days.
To register for the afternoon session,
individuals should send an email to
CPSTF@cdc.gov and include the
following information: Name, title,
organization name, organization
address, phone, email. CDC will email
web conference information from the
CPSTF@cdc.gov mailbox. Additional
logistical information regarding this
virtual meeting will be available on the
Community Guide website
(www.thecommunityguide.org) closer to
the date of the meeting.
Public Comment: Individuals who
would like to make public comments
must indicate their desire to do so with
their registration by providing their
name, organizational affiliation, and the
topic to be addressed (if known). The
requestor will receive instructions for
the public comment process for this
virtual meeting after the request is
received. A public comment period
follows the CPSTF’s discussion of each
systematic review and is limited to three
minutes per person. Public comments
will become part of the meeting
summary.
Background on the CPSTF: The
CPSTF is an independent, nonfederal
panel whose members are appointed by
the CDC Director. CPSTF members
represent a broad range of research,
practice, and policy expertise in
prevention, wellness, health promotion,
and public health. The CPSTF was
convened in 1996 by the HHS to
identify community preventive
programs, services, and policies that
increase healthy longevity, save lives
and dollars, and improve Americans’
quality of life. CDC is mandated to
provide ongoing administrative,
research, and technical support for the
operations of the CPSTF. During its
meetings, the CPSTF considers the
findings of systematic reviews of
literature on existing research and
E:\FR\FM\30JAN1.SGM
30JAN1
Agencies
[Federal Register Volume 85, Number 20 (Thursday, January 30, 2020)]
[Notices]
[Pages 5438-5439]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-01623]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business Initiatives Unit, Office of the Chief Operating Officer, CDC,
pursuant to Public Law 92-463. The grant applications and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly
[[Page 5439]]
unwarranted invasion of personal privacy.
Name of Committee: Disease, Disability, and Injury Prevention
and Control Special Emphasis Panel (SEP)- SIP20-009, State-Based
Health, Budget Impact and Cost-Effectiveness of Improved Coverage
and Uptake of Smoking Cessation.
Date: April 28, 2020.
Time: 11:00 a.m.--6:00 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant applications.
For Further Information Contact: Jaya Raman Ph.D., Scientific
Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta,
Georgia 30341; Telephone: (770) 488-6511; [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-01623 Filed 1-29-20; 8:45 am]
BILLING CODE 4163-18-P